Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2018

US$ 3,500.00

... T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products based ...

May 2018 48 pages

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2018

US$ 3,500.00

... T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 70 pages

Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) development landscape Develop and design ...

May 2018 83 pages

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H1 2018

US$ 3,500.00

... Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 102 pages

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H1 2018

US$ 3,500.00

... Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 107 pages

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H1 2018

US$ 3,500.00

... Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 155 pages

Antiulcerant Drugs: Global Markets to 2022

US$ 2,750.00

... research report categorizes the antiulcerant drugs market by type, including proton pump inhibitors, H2 receptor antagonists, gastric mucosal protective drugs, antibiotics, antacids and ... 3D printing and IoT in the growth of the antiulcerants drugs market Coverage of definition, types, causes, and treatment ...

May 2018 185 pages

Global Non-PVC IV Bag Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Non-PVC IV Bag market. Chapter 1, to describe Non-PVC IV Bag Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Non-PVC IV Bag, with ...

May 2018 103 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Surgical Blades & Scalpels Market 2018 Forecast to 2023

US$ 4,880.00

... on the Surgical Blades & Scalpels in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 103 pages

Global Blood Glucose Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Blood Glucose Testing market. Chapter 1, to describe Blood Glucose Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Blood Glucose Testing, with ...

May 2018 100 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Epinephrine Market 2018 Forecast to 2023

US$ 4,880.00

... This report focuses on the Epinephrine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 104 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Cystoscope Market 2018 Forecast to 2023

US$ 4,880.00

... This report focuses on the Cystoscope in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 103 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) All Vaccine Market 2018 Forecast to 2023

US$ 4,880.00

... report focuses on the All Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... GSK Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 105 pages

Global Pharmaceutical Blister Packaging Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Pharmaceutical Blister Packaging market. Chapter 1, to describe Pharmaceutical Blister Packaging Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Pharmaceutical Blister Packaging, with ...

May 2018 104 pages

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H1 2018

US$ 3,500.00

... Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 123 pages

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) development landscape Develop ...

May 2018 66 pages

RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) development landscape Develop and design ...

May 2018 63 pages

Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) development landscape Develop and design ...

May 2018 77 pages

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 129 pages

Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein 8 or HIF1A) - Pipeline Review, H1 2018

US$ 3,500.00

... also reviews key players involved in Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein 8 or HIF1A) targeted therapeutics development with respective ...

May 2018 74 pages

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2018

US$ 3,500.00

... Toll Like Receptor 3 (CD283 or TLR3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 67 pages

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H1 2018

US$ 3,500.00

... Toll Like Receptor 8 (CD288 or TLR8) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 75 pages

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 132 pages

Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025

US$ 5,950.00

The global pharmacokinetics services market size is expected to reach USD 1.2 billion by 2025, according to a new report by Grand ... entities in U.S. has resulted in North America accounting for the largest share in 2017 Asia Pacific is expected to grow lucratively throughout the forecast ...

May 2018 100 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liposome Drug Delivery Market 2018 Forecast to 2023

US$ 4,880.00

... focuses on the Liposome Drug Delivery in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 100 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Medical Adhesive Tapes Market 2018 Forecast to 2023

US$ 4,880.00

... focuses on the Medical Adhesive Tapes in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 108 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Medical Asparaginase Market 2018 Forecast to 2023

US$ 4,880.00

... focuses on the Medical Asparaginase in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

May 2018 101 pages

Global Vinblastinesulphate (CAS 143-67-9) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Vinblastinesulphate (CAS 143-67-9) market. Chapter 1, to describe Vinblastinesulphate (CAS 143-67-9) Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Vinblastinesulphate (CAS 143-67-9), with ...

May 2018 109 pages

Global Inhaled Nitric Oxide Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... on the Inhaled Nitric Oxide in global market, especially in ... global Inhaled Nitric Oxide market. Chapter 1, to describe Inhaled Nitric Oxide Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Inhaled Nitric Oxide ...

May 2018 103 pages

United States Chlorhexidine Gluconate (CHG) Solution Market by Manufacturers, States, Type and Application, Forecast to 2023

US$ 4,480.00

... Others There are 17 Chapters to deeply display the United States Chlorhexidine Gluconate (CHG) Solution market. Chapter 1, to describe Chlorhexidine Gluconate (CHG) Solution Introduction, product type and application, market ...

May 2018 105 pages

United States Botox Market by Manufacturers, States, Type and Application, Forecast to 2023

US$ 4,480.00

... to deeply display the United States Botox market. Chapter 1, to describe Botox Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze ...

May 2018 108 pages

United States Active Pharmaceutical Ingredients Market by Manufacturers, States, Type and Application, Forecast to 2023

US$ 4,480.00

... Others There are 17 Chapters to deeply display the United States Active Pharmaceutical Ingredients market. Chapter 1, to describe Active Pharmaceutical Ingredients Introduction, product type and application, market overview, market ...

May 2018 103 pages

Global Pharmaceuticals Industry Profile & Value Chain Analysis

US$ 495.00

Global Pharmaceuticals Industry Profile & Value Chain Analysis SUMMARY Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and ...

May 2018 48 pages

Global Glutathione Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Glutathione, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

May 2018 109 pages

Q Fever - Pipeline Review, H1 2018

US$ 2,000.00

... . The Q Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Q Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

May 2018 38 pages

Interleukin 1 (IL1) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Interleukin 1 (IL1) development landscape Develop and design in-licensing and ...

May 2018 106 pages

NAD Dependent Protein Deacetylase Sirtuin 1 (SIR2 Like Protein 1 or Sirtuin Type 1 or Regulatory Protein SIR2 Homolog 1 or SIRT1 or EC 3.5.1.) - Pipeline Review, H1 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding NAD Dependent Protein Deacetylase Sirtuin 1 (SIR2 Like Protein 1 or Sirtuin Type 1 or Regulatory Protein SIR2 Homolog 1 or SIRT1 or EC 3.5.1.) development landscape Develop ...

May 2018 44 pages

T Lymphocyte Activation Antigen CD86 (Activation B7-2 Antigen or CTLA 4 Counter Receptor B7.2 or CD86) - Pipeline Review, H1 2018

US$ 3,500.00

... T Lymphocyte Activation Antigen CD86 (Activation B7-2 Antigen or CTLA 4 Counter Receptor B7.2 or CD86) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 64 pages

Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) development landscape Develop ...

May 2018 42 pages

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H1 2018

US$ 3,500.00

... 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

May 2018 66 pages

EUROPE CHRONIC IDIOPATHIC CONSTIPATION (CIC) DRUG MARKET FORECAST 2018-2026

US$ 1,250.00

... needs of society and awareness towards leading a healthy life. The Europe chronic idiopathic constipation drug market is estimated to grow at a CAGR of 8.96% during ... in this market. COMPETITIVE INSIGHTS Major players in the Europe CIC drug market include Progenics Pharmaceuticals Inc, Theravance Biopharma Inc ...

May 2018 62 pages

GLOBAL CHRONIC IDIOPATHIC CONSTIPATION (CIC) DRUG MARKET FORECAST 2018-2026

US$ 2,500.00

KEY FINDINGS Global Chronic Idiopathic Constipation drug market is estimated to grow at a CAGR ... growth opportunities. REGIONAL INSIGHTS Geographically, the global CIC drug market is segmented four major regions ... adopted by the various market players of global CIC drug market. The other strategies include ...

May 2018 120 pages

NORTH AMERICA CHRONIC IDIOPATHIC CONSTIPATION (CIC) DRUG MARKET FORECAST 2018-2026

US$ 1,250.00

KEY FINDINGS The North America Chronic Idiopathic Constipation Drug Market is expected to grow at a CAGR of 6.95% over the forecast period. ... some of the factors driving the market MARKET INSIGHTS The North America chronic idiopathic constipation drug market is segmented on the basis of drug types and on the ...

May 2018 69 pages

ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

US$ 1,250.00

KEY FINDINGS The Asia Pacific ophthalmic drugs and devices market holds ... , with the shift of clinical activities to Asia Pacific region. The Asia-Pacific region has extremely assorted healthcare systems; each ... Major factors which are driving the ophthalmic drug market in China include the rising geriatric ...

May 2018 105 pages

EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

US$ 1,250.00

... led to the increased trust in the drugs market, which is a key factor driving growth in the Europe ophthalmology drug and devices market. By the end of the ... ageing population. On the other hand, it is the Russian ophthalmic drugs and devices market that is anticipated to exhibit the highest CAGR over the ...

May 2018 110 pages

GLOBAL ANTITHROMBOTIC DRUGS MARKET FORECAST 2018-2026

US$ 2,500.00

... . Propelled by these factors, the global Antithrombotic drugs market is anticipated to evolve further at a CAGR of 6.83% over the forecast period of 2018-2026. MARKET INSIGHTS The antithrombotic drug market is segmented on the basis ...

May 2018 132 pages

GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

US$ 2,500.00

... of awareness among people regarding ophthalmology. REGIONAL INSIGHTS Geographically, the global ophthalmic drugs & devices market is segmented into North America, Europe, Asia-Pacific ...

May 2018 150 pages

NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

US$ 1,250.00

... among all age group, gender and racial group in North America. As a result, the North America ophthalmic drugs and devices market is expected to progress at a CAGR of ... . Increasing pharmaceuticals market is the key driver for the US ophthalmic drug market. Also, as the prevalence of eye disorders in the US is ...

May 2018 111 pages

Global Artificial Pancreas Devices Systems Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... Clinics There are 15 Chapters to deeply display the global Artificial Pancreas Devices Systems market. Chapter 1, to describe Artificial Pancreas Devices Systems Introduction, product scope, market overview, market opportunities, market ...

May 2018 103 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1